The concept of value is expanding beyond the traditional payer focus. In this micro-tutorial, we describe expanded value drivers that payers now consider, and how to address the challenges of incorporating them into payer/HTA frameworks and generating robust supporting evidence.
Tutors
Content
Audience
To schedule a meeting to discuss this work, please contact our experts.
Jump to a slide with the slide dots.
CAR-T innovation in solid tumors shows mixed results at ASCO® 2025, progress seen, but safety, delivery & durability challenges remain.
Read moreTracking key 2025 ASCO® debates in IO, cell therapy, and KRAS—shaping the next standard of cancer care.
Read moreParallels between EMA & JCA reveal risks of imbalance in EU HTA. Learn how to ensure fair, inclusive JCA implementation.
Read more